Comprehensive Toileting Program
Recruiting now · Phase 4
Conditions studied: Encopresis, ASD
In brief
The current study aims to monitor fecal continence after autistic youth complete enuresis treatment and for individuals who continue to experience encopresis after acquiring urine continence, evaluate a caregiver-mediated version of a Multidisciplinary Intervention for Encopresis (CM-MIE) delivered via telehealth to determine efficacy in a randomized clinical trial.
Key facts
- Study ID
- NCT07226739
- Run by
- Emory University
- People needed
- 150
- Starts
- 2026-06-01
- Expected to finish
- 2031-01-01
- Last updated by the study team
- 2026-06-18
Who can join
Age: 5 and older, up to 12. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 5 to 12
- Diagnosis of an intellectual or developmental delay (excluding individuals with ADHD alone)
- Encopresis (more than 1 incontinent BM a week)
- Required for pre-randomization phase only: Enuresis (> 1 incontinent urination per day when on a consistent toileting sit schedule)
- At least one caregiver who speaks and understands English
You may not qualify if…
- Unresolved medical condition that would impede toilet training (e.g., interference with sphincter control, short gut syndrome, urinary tract or gastrointestinal infection, unexplained diarrhea, recent intestinal surgery, inflammatory bowel disease)
- Failed intensive toileting treatment in the past 2 yrs with protocols akin to study
- Current serious behavioral or psychiatric disorder that requires another treatment
- Current or planned other intervention (behavioral or medical) for incontinence
Where it is running
- Marcus Autism Center — Atlanta, Georgia, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.